Multi‐Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 07.08.2026. Verfasst von Yuanyuan Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Tryptophan, Glycolysis, Non-alcoholic Fatty Liver Disease, Protective Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Youth Science Foundation of Guangxi Medical University.
Abstract (Originalsprache)
Metabolic associated fatty liver disease (MAFLD) has high morbidity and tragically lacks effective therapeutic remedies. Tormentic acid (TA) has been shown to have therapeutic effect on liver fibrosis, but its role in MAFLD remains unknown. Therefore, we employed multi‐omics analyses to investigate the effects of TA on MAFLD. In this study, male C57BL/6J mice were fed a methionine‐ and choline‐ deficiency (MCD) diet to induce MAFLD and subsequently treated with TA for 4 weeks. The therapeutic efficacy of TA was then evaluated through histopathological examination and biochemical analysis. In addition, multi‐omics analyses including transcriptomics, proteomics and metabolomics were conducted to identify potential pathways associated with TA treatment. Finally, key genes and proteins in the identified pathways were validated by qPCR and Western blot. Our results showed that TA significantly alleviated liver damage and excessive lipid accumulation. Importantly, our integrative multi‐omics analyses identified tryptophan metabolism and glycolysis as pivotal pathways associated with TA treatment in our fatty liver mouse model. Subsequent validation demonstrated the TA‐induced upregulation of IDO2 and HAAO, suggesting engagement of tryptophan metabolism. Concurrently, TA treatment downregulated HK2, PFKP, and PKM2, indicative of altered rate‐limiting glycolytic enzyme expression. These findings suggest that TA alleviates MCD diet‐induced MAFLD, potentially involving modulation of enzyme expression in tryptophan metabolism and glycolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Guangxi Medical University, Nanning, China.
ORCID-Profile: Yuanyuan Wei, Jinbin Wei, Xiao Ma
Förderung
- Youth Science Foundation of Guangxi Medical University
Zitieren
APA
Wei, Y., Wei, D., Lu, J., Wei, L., Lin, W., Wei, J., & Ma, X. (2026). Multi‐Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70310
Vancouver
Wei Y, Wei D, Lu J, Wei L, Lin W, Wei J, et al. Multi‐Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70310
BibTeX
@article{Wei2026,
author = {Wei, Yuanyuan and Wei, Dingyi and Lu, Jingyang and Wei, Lulin and Lin, Weijia and Wei, Jinbin and Ma, Xiao},
title = {Multi‐Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70310}
}
EUVIMED